Work

Genetic variation in CYP3A43 explains racial difference in olanzapine clearance

Year: 2011

Type: article

Source: Molecular Psychiatry

DOI: 10.1038/mp.2011.38

Authors: K L Bigos, R R Bies, B G Pollock, J J Lowy, F Zhang, D R Weinberger

Institutions: National Institutes of Health, National Institute of Mental Health, Indiana University Indianapolis, Indiana University School of Medicine, Centre for Addiction and Mental Health, University of Toronto, Rotman Research Institute

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Eli Lilly and Company, National Institutes of Health, National Institute of Mental Health, NHLBI Division of Intramural Research

Awards: Characterization of Genetic Mechanisms Contributing to Neuropsychiatric Disorder, Replication of Schizophrenia Associations in CATIE, G975365284

OpenAlex ID: W2024912502

FWCI: 5.255

Cites: 23

Cited by: 68

Related to: 10